openPR Logo
Press release

COPD and Asthma Devices Market New Technology, Application, Type, Customer Segments, and Top Key Players 3M Health Care, Allied Healthcare Products, Inc., Sunovion Pharmaceuticals, Inc., GF Healthcare Products, Smith Medicals, Inc., Lincare Holdings, Inc.

10-15-2018 09:20 PM CET | Health & Medicine

Press release from: Allied Market Research

COPD and Asthma Devices Market New Technology, Application,

Global COPD and asthma devices market is expected to reach $41,355.2 million by 2022, according to a new report by Allied Market Research . The drug powder inhaler was the highest revenue-generating segment, accounting for over half of the share in 2015. This segment is expected to maintain its dominance throughout the forecast period.

The factors hampering the market growth include environmental concerns associated with metered dose inhalers (MDI) and high cost of selected inhalation devices. Regulatory authorities such as U.S. food and drug administration (USFDA) across several regions have banned the production and sales of MDIs, as they release environmentally hazardous gases such as chlorofluorocarbon (CFC) and hydrofluoroalkanes (HFA). Thus, soft mist inhalers (SMIs) and nebulizers are expected to replace MDIs for the treatment of respiratory diseases in the near future.

Get sample copy of this report at:
https://www.alliedmarketresearch.com/request-sample/579

Compressor nebulizers constitute around four-fifths share of the overall nebulizers market, owing to their perpetual usage in home healthcare medication and widespread availability across various regions. Nebulizers are electric- or battery-powered machines, which dispense the medication in the form of fine mist. They are used in home healthcare set-ups for debilitated patients, geriatric, and children. However, the large size of nebulizers and the need for continuous power supply are expected to hinder the market growth.

Key findings of COPD and Asthma Devices Market:

• Drug powder inhalers (DPIs) segment is projected to grow at a significant CAGR of 5.7% during the forecast period.

• North America was the leading region in 2015, and is expected to continue its dominance throughout the analysis period.

• The COPD and asthma devices market in Europe is projected to grow at a CAGR of 6.1%.

• The compressor nebulizers segment is expected to register a CAGR of 5.4%.

Get customized copy of the report at:
https://www.alliedmarketresearch.com/request-for-customization/579

North America is expected to remain the highest revenue-generating region, owing to widespread and early adoption of inhalers & nebulizers and large pool of patients suffering from respiratory diseases. Moreover, the Asia-Pacific region is expected to grow rapidly due to rising healthcare expenditure, growing awareness of advanced portable COPD & asthma devices, and increasing disposable income.

Key players in the market:

• GlaxoSmithKline Plc
• Novartis AG
• Merck & Co.Inc.
• AstraZeneca Plc
• Philips Healthcare
• 3M Health Care
• Allied Healthcare ProductsInc.
• Sunovion Pharmaceuticals Inc.
• GF Healthcare Products
• Smith Medicals Inc.
• Lincare Holdings Inc.
• Baxter International.


Chapter: 1 INTRODUCTION

1.1 Report description
1.2 Key benefits
1.3 Key market segments
1.4 Research methodology

1.4.1 Primary research
1.4.2 Secondary Research
1.4.3 Analyst tools and models

Chapter: 2 EXECUTIVE SUMMARY

2.1 CXO perspective
2.2 Market beyond what to expect by 2027

2.2.1 Moderate growth scenario
2.2.2 Rapid growth scenario
2.2.3 Diminishing growth scenario

Chapter: 3 MARKET OVERVIEW

3.1 Market definition and scope
3.2 Key findings

3.2.1 Top impacting factors
3.2.2 Top investment pockets
3.2.3 Top winning strategies

3.3 Porters five forces analysis

3.3.1 Bargaining power of buyers (High)
3.3.2 Bargaining power of suppliers (Low to Moderate)
3.3.3 Threat of new entrants (Low)
3.3.4 Threat of substitutes (High)
3.3.5 Intense competitive rivalry

3.4 Value chain analysis
3.5 Market share analysis, 2015
3.6 Government regulations

3.6.1 COPD devices regulations in Europe and in the U.S.
3.6.2 COPD devices regulations in Asia-Pacific

3.7 Drivers

3.7.1 Daily exposure to environmental pollution
3.7.2 Increase in population susceptible to indoor air pollutants
3.7.3 Portability of the drug delivery devices
3.7.4 Increasing population of Active smokers
3.7.5 Rising government initiatives

3.8 Restraints

3.8.1 Increasing price competition and deterioration of material quality
3.8.2 Overall high cost of asthma treatment is a challenge for the patients
3.8.3 Incompetent reimbursement support

3.9 Opportunities

3.9.1 Patent expiration for blockbuster drugs
3.9.2 Soft Mist Inhalers (SMIs): future growth driver

Get full access to the summary of report at:
https://www.alliedmarketresearch.com/COPD-asthma-devices-market

About Us:

Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:
Sona Padman
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1?855?550-5975
help@alliedmarketresearch.com
Web: www.alliedmarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release COPD and Asthma Devices Market New Technology, Application, Type, Customer Segments, and Top Key Players 3M Health Care, Allied Healthcare Products, Inc., Sunovion Pharmaceuticals, Inc., GF Healthcare Products, Smith Medicals, Inc., Lincare Holdings, Inc. here

News-ID: 1305012 • Views:

More Releases from Allied Market Research

Thermoplastic Composites Market Business Opportunities, Challenges, Drivers and Restraint Research Report by 2027
Thermoplastic Composites Market Business Opportunities, Challenges, Drivers and …
The global thermoplastic Composites market is presently driven by the automotive, construction and aerospace industries. In the aerospace & defense industry, the use of thermoplastic composites is primarily intended to minimize the total weight and corrosion in the aircraft structure. In addition, maintenance costs for aircraft produced using composites have significantly decreased compared with maintenance costs for aircraft produced using conventional materials. Thermoplastic composites having various properties including insubstantial weight,
Glass Fiber Reinforced Plastics (GFRP) Composites Market to Reach $37.2 Billion …
Allied Market Research published a report, titled, "Glass Fiber Reinforced Plastic (GFRP) Composites Market by Resin Type (Polyester Resin, Vinyl Ester Resin, Epoxy Resin, Polyurethane Resin, and Others), Process (Manual Process, Continuous Process, Compression Molding, and Injection Molding), and End-Use Industry (Aerospace and Defense, Construction, Wind Energy, Automotive, Electrical and Electronics, and Others): Global Opportunity Analysis and Industry Forecast, 2022-2032". According to the report, the global glass fiber reinforced plastic
India Bitumen Market Statistics, Size Will Hit $6.8 Billion By 2032 | Growth With Recent Trends & Demand
India Bitumen Market Statistics, Size Will Hit $6.8 Billion By 2032 | Growth Wit …
Bitumen is a mixture of viscous, highly sticky, and black organic liquids, which is soluble in carbon disulfide and primarily consists of condensed polycyclic aromatic hydrocarbons. It is a crucial component of asphalt, which is used to build roads, streets, and other parts of infrastructure. One of the primary applications of bitumen is in road construction. It is used as a binder in asphalt concrete, which is a mixture of
Mining Metal Market Size to Worth $1.6 Trillion by 2032 | Major Companies, Strategies and New Trends
Mining Metal Market Size to Worth $1.6 Trillion by 2032 | Major Companies, Strat …
Allied Market Research recently unveiled a report titled "Mining Metal Market," forecasting trends from 2023 to 2032. This market, categorized by type and end-use industry, is set to expand from $1.0 trillion in 2022 to $1.6 trillion by 2032, with a notable CAGR of 5.1% during 2023-2032. 𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐟𝐨𝐫 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐃𝐅 : https://www.alliedmarketresearch.com/request-sample/504 Prime Determinants of Growth: Several factors fuel the growth of the global mining metal market, including the shift

All 5 Releases


More Releases for COPD

Copd CBD Gummies: Reviews (Shocking Facts) Copd CBD Oil "Ingredients" Pain Relie …
Copd CBD Gummies: With the increasing need for both individual and expert degrees, the stress and also stress are also enhancing. Individuals are using various methods to fight it. However, as a result of much less time for self, it is really hard. Here the natural herbs and supplements have actually discovered their way into our lives. The Copd CBD Oil are instances of super-effective natural supplements. The CBD existing
Power Harmonica to Cure Chronic Asthma & COPD
Power Harmonica is a free reed wind musical instrument. It is small rectangular shaped musical instrument. It has 48 number of holes which makes it special and different from other harmonica's. It's a pocket-friendly musical instrument. Power Harmonica is used as a natural treatment for many types of lung disorders and has no side effects. To play Power Harmonica there is no need of having a musical background it can be
COPD Therapeutics Global Market Research Report 2019
COPD Therapeutics Report by Material, Application, and Geography � Global Forecast to 2022 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, united Kingdom, Japan, South Korea and China). Access more details about this report at: https://www.research2reports.com/report-medical-devices/copd-therapeutics-market/80858 The report firstly introduced the COPD Therapeutics basics: definitions, classifications, applications and market
Global COPD and Asthma Devices Market Size
According to a new report, Global COPD and Asthma Devices Market, published by KBV Research, The Global COPD and Asthma Devices Market attained a market size of $ 27,465.1 Million in 2015 and is expected to reach $ 39,051.4 Million by 2022 growing at a CAGR of 5.2 % CAGR during 2016 – 2022. The Asia Pacific market dominated the Global COPD and Asthma Devices Market in 2015 and would
COPD Drug Market Opportunity & Clinical Pipeline Analysis
Close to 1 Billion people worldwide suffer from respiratory or pulmonary diseases. In the respiratory therapeutic domain, Asthma and COPD are the major categories, accounting for close to 75% of the total patient for respiratory or pulmonary diseases. Chronic obstructive pulmonary disease (COPD) is a disease which progresses in the lungs and requires treatment all through the life. It is an inflammatory disorder which is characterized by obstruction in the
04-10-2017 | Health & Medicine
TMR
Asthma and COPD Drugs Market: High Costs of Asthma and COPD Drugs and Consumer A …
Asthma is a disease characterized by recurrent attacks of coughing, chest-tightening, breathlessness, and wheezing as the airways narrow and swell that vary in severity and frequency. COPD is a disease of the lungs characterized by obstruction to airflow that interferes with normal breathing. According to the WHO, COPD accounted for over 3 million deaths in 2012, which is equal to 6% of all deaths globally in that year. Moreover, the